0001104659-21-060161.txt : 20210503 0001104659-21-060161.hdr.sgml : 20210503 20210503154211 ACCESSION NUMBER: 0001104659-21-060161 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210503 DATE AS OF CHANGE: 20210503 EFFECTIVENESS DATE: 20210503 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ashvattha Therapeutics, Inc. CENTRAL INDEX KEY: 0001668528 IRS NUMBER: 474803849 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-397980 FILM NUMBER: 21883331 BUSINESS ADDRESS: STREET 1: 1235 RADIO ROAD, SUITE 200 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: (650) 868-5853 MAIL ADDRESS: STREET 1: 1235 RADIO ROAD, SUITE 200 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: Ashvattha Therapeutics, LLC DATE OF NAME CHANGE: 20160303 D 1 primary_doc.xml X0708 D LIVE 0001668528 Ashvattha Therapeutics, Inc. 1235 RADIO ROAD, SUITE 200 REDWOOD CITY CA CALIFORNIA 94065 (650) 868-5853 CALIFORNIA None Ashvattha Therapeutics, LLC Corporation true Jeffrey Cleland 255 Aberdeen Drive San Carlos CA CALIFORNIA 94070 Executive Officer Director Sujatha Kannan 6840 Green Hollow Way Highland MD MARYLAND 20777 Director Kannan Rangaramanujam 6840 Green Hollow Way Highland MD MARYLAND 20777 Executive Officer Director Barbara Slusher 1235 Radio Road, Suite 200 Redwood City CA CALIFORNIA 94065 Director Jay Zaveri 1235 Radio Road, Suite 200 Redwood City CA CALIFORNIA 94065 Director George Montgomery 1235 Radio Road, Suite 200 Redwood City CA CALIFORNIA 94065 Director Biotechnology Decline to Disclose 06b false 2021-04-16 false true true true Convertible notes and warrants false 0 GP Nurmenkari Inc. 153480 None None 22 ELIZABETH STREET, SONO SQUARE, SUITE 1J NORWALK CT CONNECTICUT 06854 AL ALABAMA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA IL ILLINOIS IN INDIANA MA MASSACHUSETTS MI MICHIGAN NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA TX TEXAS VT VERMONT false 9564619 7725000 1839619 false 39 618000 0 GP Nurmenkari Inc. is entitled to 8% of the gross proceeds of its portion of the offering and warrants amounting to 8% of the gross proceeds of its portion of the offering. 0 false Ashvattha Therapeutics, Inc. /s/ Jeffrey Cleland Jeffrey Cleland President 2021-04-29